PR Log - Feb 01, 2013 - MENLO PARK, Calif. -- SR Ventures LLC is pleased to announce the addition of Dr. Sablin to it's team.

Michael Corwin, founder of SR Ventures, LLC commented "Dr. Sablin is a great addition to our team of professionals.  Dr. Sablin is an expert in biotech and will lead our life sciences initiatives to review all biotech, medical device, and pharmaceutical opportunities".

Dr. Sablin is a serial entrepreneur, a private investor, and a consultant in the biotech industry. He was a founder and CEO of Selena Pharmaceuticals, Inc., which had a successful exit of over $40M for it's investors having a total investment of $500K in development. Dr. Sablin is a co-founder of Medivation, Inc. (NASDAQ :MDVN), a biotech company Inc. that is a $4B corporation today. Dr. Sablin served as a board member of an Investment Committee at the Russian Venture Company, a government organization established to stimulate growth of the biomedical industry. Currently, Dr. Sablin serves as a board member for Medistem, Inc., (MEDS) a clinical stage San Diego based company, which is focused on the development of a the new type of the universal donor adult stem cell product for the therapy of a variety degenerative diseases. Prior to moving into biotech industry, Dr. Sablin was a research scientist at UCSF. Dr.Sablin received his PhD in biochemistry from the Lomonosov Moscow State University. Dr. Sablin is the author of over 40 scientific publications and patents.

Read Full Story - Dr. Sergey Sablin Joins SR Ventures LLC as SVP of Life Sciences | More news from this source

Press release distribution by PRLog